Total List

2017

2016

1.Pletz MW, Ewig S, Rohde G, Schuette H, Rupp J, Welte T, Suttorp N, Forstner C; CAPNETZ Study Group. Impact of pneumococcal vaccination in children on serotype distribution in adult community-acquired pneumonia using the serotype-specific multiplex urinary antigen detection assay. Vaccine. 2016 Apr 29;34(20):2342-8. doi: 10.1016/j.vaccine.2016.03.052. Epub 2016 Mar 24.
PubMed
2.Suttorp N, Welte T, Marre R, Stenger S, Pletz M, Rupp J, Schütte H, Rohde G; CAPNETZ-Studiengruppe. CAPNETZ. The competence network for community-acquired pneumonia (CAP). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2016 Apr;59(4):475-81. doi: 10.1007/s00103-016-2318-7. German.
PubMed
3.Forstner C, Rohde G, Rupp J, Schuette H, Ott SR, Hagel S, Harrison N, Thalhammer F, von Baum H, Suttorp N, Welte T, Pletz MW; CAPNETZ Study Group.Community-acquired Haemophilus influenzae pneumonia - New insights from the CAPNETZ study. J Infect. 2016 May;72(5):554-63. doi: 10.1016/j.jinf.2016.02.010. Epub 2016 Mar 3.
PubMed
4.Kolditz M, Ewig S, Klapdor B, Schütte H, Winning J, Rupp J, Suttorp N, Welte T, Rohde G; CAPNETZ study group.Community-acquired pneumonia as medical emergency: predictors of early deterioration.Thorax. 2015 Jun;70(6):551-8. doi: 10.1136/thoraxjnl-2014-206744. Epub 2015 Mar 17.
PubMed
5.Andersen SB, Baunbæk Egelund G, Jensen AV1, Petersen PT, Rohde G, Ravn P.Failure of CRP decline within three days of hospitalization is associated with poor prognosis of Community-acquired Pneumonia.Infect Dis (Lond). 2017 Apr;49(4):251-260. doi: 10.1080/23744235.2016.1253860. Epub 2016 Nov 25.
PubMed
6.Kolditz M, Scherag A, Rohde G, Ewig S, Welte T, Pletz M; CAPNETZ Study Group.Comparison of the qSOFA and CRB-65 for risk prediction in patients with community-acquired pneumonia.Intensive Care Med. 2016 Dec;42(12):2108-2110. Epub 2016 Sep 19.
PubMed

2015

1.Kolditz M, Ewig S, Schütte H, Suttorp N, Welte T, Rohde G; The CAPNETZ study group. Assessment of oxygenation and comorbidities improves outcome prediction in patients with community-acquired pneumonia with a low CRB-65 score. J Intern Med. 2015 Aug;278(2):193-202. doi: 10.1111/joim.12349. Epub 2015 Feb 13.
PubMed
 
2.Rohde GG, Koch A, Welte T. Randomized double blind placebo-controlled study to demonstrate that antibiotics are not needed in moderate acute exacerbations of COPD - The ABACOPD Study. BMC Pulm Med. 2015 Jan 27;15:5. doi: 10.1186/1471-2466-15-5.
PubMed
3.Dumke R, Schnee C, Pletz MW, Rupp J, Jacobs E, Sachse K, Rohde G; Capnetz Study Group. Mycoplasma pneumoniae and Chlamydia spp. infection in community-acquired pneumonia, Germany, 2011-2012. Emerg Infect Dis. 2015 Mar;21(3):426-34. doi: 10.3201/eid2103.140927.
PubMed
4.Kolditz M, Ewig S, Klapdor B, Schütte H, Winning J, Rupp J, Suttorp N, Welte T, Rohde G; CAPNETZ study group. Community-acquired pneumonia as medical emergency: predictors of early deterioration. Thorax. 2015 Jun;70(6):551-8. doi: 10.1136/thoraxjnl-2014-206744. Epub 2015 Mar 17.
PubMed

2014

1.Majcher-Peszynska J, Loebermann M, Klammt S, Frimmel S, Mundkowski RG, Welte T, Reisinger EC, Drewelow B; CAPNETZ Study Group. Ampicillin/sulbactam in elderly patients with community-acquired pneumonia. Infection. 2014 Feb;42(1):79-87. doi: 10.1007/s15010-013-0518-8. Epub 2013 Aug 1.
PubMed
2.Bierbaum S, Forster J, Berner R, Rücker G, Rohde G, Neumann-Haefelin D, Panning M; CAPNETZ study group. Detection of respiratory viruses using a multiplex real-time PCR assay in Germany, 2009/10. Arch Virol. 2014 Apr;159(4):669-76. doi: 10.1007/s00705-013-1876-3. Epub 2013 Oct 15.
PubMed
 
3.Pletz MW, Terkamp C, Schumacher U, Rohde G, Schütte H, Welte T, Bals R; CAPNETZ-Study Group.Vitamin D deficiency in community-acquired pneumonia: low levels of 1,25(OH)2 D are associated with disease severity. Respir Res. 2014 Apr 27;15(1):53. doi: 10.1186/1465-9921-15-53.
PubMed
4.Krüger S, Ewig S, Giersdorf S, Hartmann O, Frechen D, Rohde G, Suttorp N, Welte T; CAPNETZ study group. Dysnatremia, vasopressin, atrial natriuretic peptide and mortality in patients with community-acquired pneumonia: Results from the german competence network CAPNETZ. Respir Med. 2014 Nov;108(11):1696-705. doi: 10.1016/j.rmed.2014.09.014. Epub 2014 Oct 2.
PubMed

2013

1.Pletz MW, Michaylov N, Schumacher U, van der Linden M, Duesberg CB, Fuehner T, Klugman KP, Welte T, Makarewicz O. Antihypertensives suppress the emergence of fluoroquinolone-resistant mutants in pneumococci: an in vitro study. Int J Med Microbiol. 2013 May;303(4):176-81. doi: 10.1016/j.ijmm.2013.02.014. Epub 2013 Mar 14.
PubMed

2012

1.Zobel K, Martus P, Pletz MW, Ewig S, Prediger M, Welte T, Buhling F, Study Group. Interleukin 6, lipopolysaccharide-binding protein and interleukin 10 in the prediction of risk and etiologic patterns in patients with community-acquired pneumonia: results from the German competence network CAPNETZ. BMC Pulm Med. 2012 Feb 20;12:6.
PubMed
2.Klapdor B, Ewig S, Schaberg T, Rohde G, Pletz MW, Schütte H, Welte T; for the CAPNETZ study group. Presentation, etiology and outcome of pneumonia in younger nursing home residents. J Infect. 2012 Jul;65(1):32-38. Epub 2012 Feb 10.
PubMed
3.Lepper PM, Ott S, Nüesch E, von Eynatten M, Schumann C, Pletz MW, Mealing NM, Welte T, Bauer TT, Suttorp N, Jüni P, Bals R, Rohde G; on behalf of the German Community Acquired Pneumonia Competence Network (CAPNETZ). Serum glucose levels for predicting death in patients admitted to hospital for community acquired pneumonia: prospective cohort study. BMJ. 2012 May 28;344:e3397. doi: 10.1136/bmj.e3397.
PubMed
4.Kolditz M, Höffken G, Martus P, Rohde G, Schütte H, Bals R, Suttorp N, Pletz MW; CAPNETZ study group. Serum cortisol predicts death and critical disease independently of CRB-65 score in community-acquired pneumonia: a prospective observational cohort study. BMC Infect Dis. 2012 Apr 13;12:90.
PubMed
5.Klapdor B, Ewig S, Pletz MW, Rohde G, Schütte H, Schaberg T, Welte T; for the CAPNETZ study group.Community-acquired pneumonia in the younger is an entity of its own. Eur Respir J. 2012 May;39(5):1156-61. Epub 2011 Nov 16.
PubMed
6.Ewig S, Klapdor B, Pletz MW, Rohde G, Schütte H, Schaberg T, Bauer TT, Welte T; for the CAPNETZ study group.Nursing-home-acquired pneumonia in Germany: an 8-year prospective multicentre study. Thorax. 2012 Feb;67(2):132-8. Epub 2011 Nov 5.
PubMed
7.Pletz MW, von Baum H, van der Linden M, Rohde G, Schütte H, Suttorp N, Welte T. The Burden of Pneumococcal Pneumonia - Experience of the German Competence Network CAPNETZ. Pneumologie. 2012 Aug;66(8):470-475. Epub 2012 Aug 8.
PubMed

2011

1.Ewig S, Hecker H, Suttorp N, Marre R, Welte T; the CAPNETZ study group. Moxifloxacin monotherapy versus ß-lactam mono- or combination therapy in hospitalized patients with community-acquired pneumonia. J Infect. 2011 Mar;62(3):218-25. Epub 2011 Jan 27.
PubMed
2.von Baum H, Schweiger B, Welte T, Marre R, Suttorp N, Pletz MW, Ewig S; the THE CAPNETZ STUDY GROUP. How deadly is seasonal influenza associated pneumonia? The German Competence Network for Community-acquired pneumonia (CAPNETZ). Eur Respir J. 2011 May;37(5):1151-7. Epub 2010 Sep 3
PubMed
3.Rudolf D, Michaylov N, van der Linden M, Hoy L, Klugman KP, Welte T, Pletz MW; on behalf of CAPNETZ study group. International pneumococcal clones equal or exceed the fitness of other strains despite the accumulation of antibiotic resistance. Antimicrob Agents Chemother. 2011 Oct;55(10):4915-7. doi: 10.1128/AAC.00250-11. Epub 2011 Aug 8.
PubMed
4.Tessmer A, Welte T, Schmidt-Ott R, Eberle S, Barten G, Suttorp N, Schaberg T; for the CAPNETZ study group. Influenza vaccination is associated with reduced severity of community acquired pneumonia. Eur Respir J. 2011 Jul;38(1):147-53. Epub 2010 Dec 9
PubMed
5.Pletz MW, van der Linden M, von Baum H, Duesberg CB, Klugman KP, Welte T; for the CAPNETZ study group. Low prevalence of fluoroquinolone resistant strains and resistance precursor strains in Streptococcus pneumoniae from patients with community-acquired pneumonia despite high fluoroquinolone usage. Int J Med Int J Med Microbiol. 2011 Jan;301(1):53-7. Epub 2010 Aug 7
PubMed

2010

1.Krüger S, Ewig S, Kunde J, Hartmann O, Suttorp N, Welte T; CAPNETZ Study Group. 2010. Pro-atrial natriuretic peptide and pro-vasopressin for predicting short-term and long-term survival in community-acquired pneumonia: results from the German Competence Network CAPNETZ. Thorax 65(3): 208-214
PubMed
2.Dumke R, von Baum H, Lück PC, Jacobs E. 2010. Subtypes and variants of Mycoplasma pneumoniae: local and temporal changes in Germany 2003-2006 and absence of a correlation between the genotype in the respiratory tract and the occurrence of genotype-specific antibodies in the sera of infected patients. Epidemiol Infect. 2010 Dec; 138(12):1829-37. Epub 2010 Mar 25
PubMed
3.Krüger S, Ewig S, Giersdorf S, Hartmann O, Suttorp N, Welte T; the CAPNETZ study group. Cardiovascular and Inflammatory Biomarkers to Predict Short- and Long-term Survival in Community-acquired Pneumonia. Am J Respir Crit Care Med.2010 Dec 1;182(11):1426-34. Epub 2010 Jul 16.
PubMed
 
4.Schnoor M, Meyer T, Suttorp N, Raspe H, Welte T, Schäfer T; the CAPNETZ Study Group.Development and evaluation of an implementation strategy for the German guideline on community-acquired pneumonia. Qual Saf Health Care. 2010 Dec;19(6):498-502. Epub 2010 Apr 13.
PubMed
5.Krüger S, Ewig S, Kunde J, Hartmann O, Marre R, Suttorp N, Welte T; on behalf of the CAPNETZ study group. Assessment of inflammatory markers in patients with community-acquired pneumonia - influence of antimicrobial pre-treatment. Results from the German competence network CAPNETZ. Clin Chim Acta. 2010 Dec 14;411(23-24):1929-34. Epub 2010 Aug 7.
PubMed
6.von Baum H, Welte T, Marre R, Suttorp N, Ewig S; CAPNETZ study group.Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: Diagnosis, incidence and predictors. Eur Respir J. 2010 Mar;35(3):598-605. Epub 2009 Aug 13.
PubMed
7.Dumke R, von Baum H, Lück PC, Jacobs E. 2010. Occurrence of macrolide-resistant
Mycoplasma pneumoniae strains in Germany. Clin Microbiol Infect. 2010 Jun;16(6):613-6. Epub 2009 Sep 17.
PubMed

2009

1.Herr C, Kandler K, Beisswenger C, Hess C, Suttorp N, Welte T, Schröder JM, Vogelmeier C and Bals R for the CAPNETZ Study Group. 2009. Suppression of pulmonary innate host defense in smokers. Thorax 64(2): 144-149.
PubMed
2.Witzenrath M, Gutbier B, Schmeck B, Tenor H, Seybold J, Kuelzer R, Grentzmann G, Hatzelmann A, van Laak V, Tschernig T, Mitchell TJ, Schudt C, Rosseau S, Suttorp N and Schütte H. 2009. Phosphodiesterase 2 inhibition diminished acute lung injury in murine pneumococcal pneumonia. Crit Care Med 37: 584–590.
PubMed
3.Witzenrath M, Schmeck B, Doehn JM, Tschernig T, Zahlten J, Loeffler JM, Zemlin M, Müller H, Gutbier B, Schütte H, Hippenstiel S, Fischetti VA, Suttorp N and Rosseau S. 2009. Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia. Crit Care Med 37: 642– 649.
PubMed
4.Welte T and Köhnlein T. 2009. Global and local epidemiology of community-acquired pneumonia: the experience of the CAPNETZ Network. Semin Respir Crit Care Med 30[2], 127-35.
PubMed
5.Tessmer A, Welte T, Martus P, Schnoor M, Marre R and Suttorp N. 2009. Impact of intravenous ß-lactam/macrolide versus ß-lactam monotherapy on mortality in hospitalized patients with community-acquired pneumonia. J Antimicrob Chemother May;63(5):1025-33.
PubMed
6.Krüger S, Ewig S, Kunde J, Hanschmann A, Marre R, Suttorp N, Welte T;  CAPNETZ study group. 2009. C-terminal provasopressin (copeptin) in patients with community-acquired pneumonia-influence of antibiotic pre-treatments: results from the German competence network CAPNETZ. J Antimicrob Chemother 64(1):159-62.
PubMed
7.von Baum H, Welte T, Marre R, Suttorp N, Lück C, Ewig S. 2009. Mycoplasma pneumoniae pneumonia revisited within the German Competence Network for Community-acquired pneumonia (CAPNETZ). BMC Infect Dis 2009 May 13;9:62.
PubMed
8.von Baum H, Welte T, Marre R, Suttorp N, Ewig S; for the CAPNETZ Study Group. 2009. Community-acquired pneumonia through enterobacteriaceae and Pseudomonas aeruginosa: diagnosis, incidence and predictors. Eur Respir J. 2009 Aug 13.
PubMed
9.Krüger S, Ewig S, Papassotiriou J, Kunde J, Marre R, von Baum H, Suttorp N, Welte T; CAPNETZ Study Group. Inflammatory parameters predict etiologic patterns but do not allow for individual prediction of etiology in patients with CAP: results from the German competence network CAPNETZ. Respir Res. 2009 Jul 12;10:65.
PubMed
10.Schnoor M, Schoefer Y, Henrich G, Raspe H, Schaefer T. General and health-related life satisfaction of patients with community-acquired pneumonia. Psychol Health Med. 2009 May;14(3):331-42.
PubMed

2008

1.Beisswenger C and Bals R. 2008. Interaction of allergic airway inflammation and innate immunity: hygiene and beyond. J Occup Med Toxicol 3 Suppl 1, S3.
PubMed
2.Borchardt J, Helbig JH and Lück PC. 2008. Occurrence and distribution of sequence types among Legionella pneumophila strains isolated from patients in Germany: common features and differences to other regions of the world. Eur J Clin Microbiol Infect Dis 27[1], 29-36.
PubMed
3.Cabanski M, Steinmüller M, Marsh LM, Surdziel E, Seeger W and Lohmeyer J. 2008. PKR regulates TLR2/TLR4-dependent signaling in murine alveolar macrophages. Am J Respir Cell Mol Biol 38[1], 26-31.
PubMed
4.Galka F, Wai SN, Kusch H, Engelmann S, Hecker M, Schmeck B, Hippenstiel S, Uhlin BE and Steinert M. 2008. Proteomic characterisation of the whole secretome of Legionella pneumophila and functional analysis of outer membrane vesicles. Infect Immun 76[5], 1825-1836.
PubMed
5.Hocke AC, Hartmann IK, Eitel J, Optiz B, Scharf S, Suttorp N and Hippenstiel S. 2008. Subcellular expression pattern and role of IL-15 in pneumococci induced lung epithelial apoptosis. Histochem Cell Biol 130 [1], 165-176.
PubMed
6.Kothe H, Bauer T, Marre R, Suttorp N, Welte T, Dalhoff K and the CAPNETZ study group. 2008. Outcome of community-acquired pneumonia: influence of age, residence status, and antimicrobial treatment. Eur Respir J 32[1], 139-146.
PubMed
7.Krüger S, Ewig S, Marre R, Papassotiriou J, Richter K, von Baum H, Suttorp N, Welte T and CAPNETZ Study Group. 2008. Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes. Eur Respir J 31[2], 349-355.
PubMed
8.Schmeck B, Beermann W, N'Guessan PD, Hocke AC, Opitz B, Eitel J, Dinh QT, Witzenrath M, Krüll M, Suttorp N and Hippenstiel S. 2008. Simvastatin Reduces Chlamydophila pneumoniae-Mediated Histone Modifications and Gene Expression in Cultured Human Endothelial Cells. Circ Res 25[102], 888-895.
PubMed
9.Schmeck B, Lorenz J, N'Guessan PD, Opitz B, van Laak V, Zahlten J, Slevogt H, Witzenrath M, Flieger A, Suttorp N, and Hippenstiel S. 2008. Histone acetylation and flagellin are essential for Legionella pneumophila-induced cytokine expression. J Immunol 181[2], 940-947.
PubMed
10.von Baum H, Ewig S, Marre R, Suttorp N, Gonschior S, Welte T, Lück C and CAPNETZ Study Group. 2008. Community-acquired Legionella pneumonia. New insights from the German competence network for community acquired pneumonia. Clin Infect Dis 46[9], 1356-1364.
PubMed

2007

1.Dumke R, Schurwanz N, Lenz M, Schuppler M, Lück C and Jacobs E. 2007. Sensitive detection of Mycoplasma pneumoniae in human respiratory tract samples by optimized real-time PCR approach. J Clin Microbiol 45[8], 2726-2730.
PubMed
2.Hammerschmidt S, Agarwal V, Kunert A, Haelbich S, Skerka C and Zipfel PF. 2007. The host immune regulator factor H interacts via two contact sites with the PspC protein of Streptococcus pneumoniae an d mediates adhesion to host epithelial cells. J Immunol 178[9], 5848-5858.
PubMed
3.Hippenstiel S, Witzenrath M, Opitz B, Schütte H, Rosseau S and Suttorp N. 2007. Neues zur Pathophysiologie der Pneumonie [New aspects of the pathophysiology of pneumonia]. Internist (Berl) 48[5], 459-60, 462-4, 466-7.
PubMed
4.Hocke AC, Lampe MP, Witzenrath M, Mollenkopf H, Zerrahn J, Schmeck B, Kessler U, Krüll M, Hammerschmidt S, Hippenstiel S, Schütte H, Suttorp N and Rosseau S. 2007. Cell-specific interleukin-15 and interleukin-15 receptor subunit expression and regulation in pneumococcal pneumonia-comparison to chlamydial lung infection. Cytokine 38[2], 61-73.
PubMed
5.Kohlhammer Y, Raspe H, Marre R, Suttorp N, Welte T, Schäfer T and CAPNETZ study group. 2007. Antibiotic treatment of community acquired pneumonia varies widely across Germany. J Infect 54[5], 446-453.
PubMed
6.Krüger S, Papassotiriou J, Marre R, Richter K, Schumann C, von Baum H, Morgenthaler NG, Suttorp N, Welte T and CAPNETZ Study Group. 2007. Pro-atrial natriuretic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia: results from the German comptetence network CAPNETZ. Intensive Care Med 33[12], 2069-2078.
PubMed
7.Lück PC, Ecker C, Reischl U, Linde HJ and Stempka R. 2007. Culture-independent identification of the source of an infection by direct amplification and sequencing of Legionella pneumophila DNA from a clinical specimen. J Clin Microbiol 45[9], 3143-3144.
PubMed
8.N'Guessan PD, Etouem MO, Schmeck B, Hocke AC, Scharf S, Vardarova K, Opitz B, Flieger A, Suttorp N and Hippenstiel S. 2007. Legionella pneumophila-induced PK Calpha-, MAPK-, and NF-kappaB-dependent COX-2 expression in human lung epithelium. Am J Physiol Lung Cell Mol Physiol 292[1], L267-L277.
PubMed
9.Opitz B, Hippenstiel S, Eitel J and Suttorp N. 2007. Extra- and intracellular innate immune recognition in endothelial cells. Thromb Haemost 98[2], 319-326.
PubMed
10.Opitz B, Rejaibi A, Dauber B, Eckhard J, Vinzing M, Schmeck B, Hippenstiel S, Suttorp N and Wolff T. 2007. IFNbeta induction by influenza A virus is mediated by RIG-I which is regulated by the viral NS1 protein. Cell Microbiol 9[4], 930-938.
PubMed
11.Paul S, Krüger S, Richter K, Muche R, Marre R, Welte T, Billich C, Gonschior S, Schumann C, Boll D, Aschoff AJ and Suttorp N. 2007. Detektion pneumonischer Infiltrate bei ambulant erworbener Pneumonie: Übereinstimmung in der Befundung der Röntgen-Thoraxaufnahme [Interobserver agreement in the assessment of pulmonary infiltrates on chest radiography in community-acquired pneumonia]. Rofo 179[11], 1152-1158.
PubMed
12.Ratzow S, Gaia V, Helbig JH, Fry NK and Lück PC. 2007. Addition of neuA, the gene encoding N-acylneuraminate cytidylyl transferase, increases the discriminatory ability of the consensus sequence-based scheme for typing Legionella pneumophila serogroup 1 strains. J Clin Microbiol 45[6], 1965-1968.
PubMed
13.Rosseau S, Hocke A, Mollenkopf H, Schmeck B, Suttorp N, Kaufmann SH and Zerrahn J. 2007. Comparative transcriptional profiling of the lung reveals shared and distinct features of Streptococcus pneumoniae and influenza A virus infection. Immunology 120[3], 380-391.
PubMed
14.Schmeck B, N'Guessan PD, Ollomang M, Lorenz J, Zahlten J, Opitz B, Flieger A, Suttorp N and Hippenstiel S. 2007. Legionella pneumophila-induced NF-kappaB- and MAPK-dependent cytokine release by lung epithelial cells. Eur Respir J 29[1], 25-33.
PubMed
15.Schnoor M, Hedicke J, Dalhoff K, Raspe H, Schäfer T and CAPNETZ Study Group. 2007. Approaches to estimate the population-based incidence of community acquired pneumonia. J Infect 55[3], 233-239.
PubMed
16.Schnoor M, Klante T, Beckmann M, Robra BP, Welte T, Raspe H, Schäfer T and CAPNETZ Study Group. 2007. Risk factors for community-acquired pneumonia in German adults: the impact of children in the household. Epidemiol Infect 135[8], 1389-1397.
PubMed
17.Schoefer Y, Schaberg T, Raspe H and Schäfer T. 2007. Determinants of influenza and pneumococcal vaccination in patients with chronic lung diseases. J Infect 55[4], 347-352.
PubMed
18.Slevogt H, Seybold J, Tiwari KN, Hocke AC, Jonatat C, Dietel S, Hippenstiel S, Singer BB, Bachmann S, Suttorp N and Opitz B. 2007. Moraxella catarrhalis is internalized in respiratory epithelial cells by a trigger-like mechanism and initiates a TLR2- and partly NOD1-dependent inflammatory immune response. Cell Microbiol 9[3], 694-707.
PubMed
19.Suttorp N, Welte T and Marre R. 2007. Community-Acquired Pneumonia. Birkhäuser Advances in Infectious Diseases. Series Editors Schmidt A, Wolff MH and Kaufmann SHE. Birkhäuser Verlag, Basel - Boston - Berlin.
20.von Wulffen W, Steinmueller M, Herold S, Marsh LM, Bulau P, Seeger W, Welte T, Lohmeyer J and Maus UA. 2007. Lung dendritic cells elicited by Fms-like tyrosine 3-kinase ligand amplify the lung inflammatory response to lipopolysaccharide. Am J Respir Crit Care Med 176[9], 892-901.
PubMed
21.Welte T. 2007. Therapie der ambulant erworbenen Pneumonie [Treatment of community acquired pneumonia]. Internist 48[5], 476-488.
PubMed
22.Witzenrath M, Gutbier B, Owen JS, Schmeck B, Mitchell TJ, Mayer K, Thomas MJ, Ishii S, Rosseau S, Suttorp N and Schütte H. 2007. Role of platelet-activating factor in pneumolysin-induced acute lung injury. Crit Care Med 35[7], 1756-1762.
PubMed

2006

1.Bauer T. 2006. CAPNETZ: Das Kompetenznetzwerk der ambulant erworbenen Pneumonie in Deutschland. [CAPNETZ: Competence network for community acquired pneumonia in Germany]. Pneumologie 60[2], 111-113.
PubMed
2.Bauer TT, Ewig S, Marre R, Suttorp N, Welte T and the CAPNETZ Study Group. 2006. CRB-65 predicts death from community-acquired pneumonia. J Intern Med 260[1], 93-101.
PubMed
3.Beisswenger C, Kandler K, Hess C, Garn H, Felgentreff K, Wegmann M, Renz H, Vogelmeier C and Bals R. 2006. Allergic airway inflammation inhibits pulmonary antibacterial host defense. J Immunol 177[3], 1833-1837.
PubMed
4.Bergmann S and Hammerschmidt S. 2006. Versatility of pneumococcal surface proteins. Microbiology 152[Pt 2], 295-303.
PubMed
5.Dumke R, Lück PC, Noppen C, Schaefer C, von Baum H, Marre R and Jacobs E. 2006. Culture-independent molecular subtyping of Mycoplasma pneumoniae in clinical samples. J Clin Microbiol 44[7], 2567-2570.
PubMed
6.Felgentreff K, Beisswenger C, Griese M, Gulder T, Bringmann G and Bals R. 2006. The antimicrobial peptide cathelicidin interacts with airway mucus. Peptides 27[12], 3100-3106.
PubMed
7.Hamann L, Glaeser C, Hamprecht A, Gross M, Gomma A and Schumann RR. 2006. Toll-like receptor (TLR)-9 promotor polymophisms and atherosclerosis. Clin Chim Acta 364[1-2], 303-307.
PubMed
8.Hammerschmidt S. 2006. Adherence molecules of pathogenic pneumococci. Curr Opin Microbiol 9[1], 12-20.
PubMed
9.Hedicke J, Schnoor M, Schübel N, Gadji D, Dalhoff K, Raspe H and Schäfer T. 2006. Ergebnisvergleich: Aktives versus passives Meldesystem bei Fällen mit ambulant erworbener Pneumonie. Ergebnisse aus dem Kompetenznetzwerk CAPNETZ [Results of a comparison: acive versus passive reporting in cases of community acquired pneumonia. Results of the German Competence Network CAPNETZ]. Gesundheitswesen 68[10], 638-642.
PubMed
10.Hermans PW, Adrian PV, Albert C, Esteavo S, Hoogenboezem T, Luijendijk IH, Kamphausen T and Hammerschmidt S. 2006. The streptococcal lipoprotein rotamase A (SlrA) is a functional peptidyl-prolyl isomerase involved in pneumococcal colonization. J Biol Chem 281[2], 968-976.
PubMed
11.Herold S, von Wulffen W, Steinmueller M, Pleschka S, Kuziel WA, Mack M, Srivastava M, Seeger W, Maus UA and Lohmeyer J. 2006. Alveolar epithelial cells direct monocyte transepithelial migration upon influenza virus infection: impact of chemokines and adhesion molecules. J Immunol 177[3], 1817-1824.
PubMed
12.Hippenstiel S, Opitz B, Schmeck B and Suttorp N. 2006. Lung epithelium as a sentinel and effector system in pneumonia - molecular mechanisms of pathogen recognition and signal transduction. Respir Res 7, 97.
PubMed
13.Koch M, Witzenrath M, Reuter C, Herma M, Schütte H, Suttorp N, Collins H and Kaufmann SH. 2006. Role of local pulmonary IFN-gamma expression in murine allergic airway inflammation. Am J Respir Cell Mol Biol 35[2], 211-219.
PubMed
14.Krüll M, Bockstaller P, Wuppermann FN, Klucken AC, Mühling J, Schmeck B, Seybold J, Walter C, Maass M, Rosseau S, Hegemann JH, Suttorp N and Hippenstiel S. 2006. Mechanisms of Chlamydophila pneumoniae-mediated GM-CSF release in human bronchial epithelial cells. Am J Respir Cell Mol Biol 34[3], 375-382.
PubMed
15.Kuhnke A, Welte T and Suttorp N. 2006. Pneumonie - erregerbasierte oder konstellationsbasierte Therapie? [Pneumonia - pathogen-based or constellation-based therapy?]. Internist (Berl) 47 Suppl 1, S14-S19.
PubMed
16.Lück PC and Steinert M. 2006. Pathogenese, Diagnostik und Therapie der Legionella-Infektion [Pathogenesis, diagnosis and therapy of Legionella infections]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 49[5], 439-449.
PubMed
17.Lück PC, Helbig JH, von Baum H and Marre R. 2006. Diagnostics and clinical disease treatment: Usefulness of microbiological diagnostic methods for detection of legionella infections. Legionella: State of the Art 30 years after its Recognition, 15-21. ASM Press, Washington D.C.
18.Maus UA, Janzen S, Wall G, Srivastava M, Blackwell TS, Christman JW, Seeger W, Welte T and Lohmeyer J. 2006. Resident alveolar macrophages are replaced by recruited monocytes in response to endotoxin-induced lung inflammation. Am J Respir Cell Mol Biol 35[2], 227-235.
PubMed
19.N'Guessan PD, Hippenstiel S, Etouem MO, Zahlten J, Beermann W, Lindner D, Opitz B, Witzenrath M, Rosseau S, Suttorp N and Schmeck B. 2006. Streptococcus pneumoniae induced p38 MAPK- and NF-kappaB-dependent COX-2 expression in human lung epithelium. Am J Physiol Lung Cell Mol Physiol 290[6], L1131-L1138.
PubMed
20.Opitz B, Püschel A, Beermann W, Hocke AC, Förster S, Schmeck B, van Laak V, Chakraborty T, Suttorp N and Hippenstiel S. 2006. Listeria monocytogenes activated p38 MAPK and induced IL-8 secretion in a nucleotide-binding oligomerization domain 1-dependent manner in endothelial cells. J Immunol 176[1], 484-490.
PubMed
21.Opitz B, Vinzing M, van Laak V, Schmeck B, Heine G, Günther S, Preissner R, Slevogt H, N'Guessan PD, Eitel J, Goldmann T, Flieger A, Suttorp N and Hippenstiel S. 2006. Legionella pneumophila induces IFNbeta in lung epithelial cells via IPS-1 and IRF3, which also control bacterial replication. J Biol Chem 281[47], 36173-36179.
PubMed
22.Schmeck B, Huber S, Moog K, Zahlten J, Hocke AC, Opitz B, Hammerschmidt S, Mitchell TJ, Kracht M, Rosseau S, Suttorp N, and Hippenstiel S. 2006. Pneumococci induced TLR- and Rac1-dependent NF-kappaB-recruitment to the IL-8 promoter in lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 290[4], L730-L737.
PubMed
23.Schmeck B, Moog K, Zahlten J, van Laak V, N'Guessan PD, Opitz B, Rosseau S, Suttorp N, and Hippenstiel S. 2006. Streptococcus pneumoniae induced c-Jun-N-terminal kinase- and AP-1 -dependent IL-8 release by lung epithelial BEAS-2B cells. Respir Res 7, 98.
PubMed
24.Schmeck B, Beermann W, van Laak V, Opitz B, Hocke AC, Meixenberger K, Eitel J, Chakraborty T, Schmidt G, Barth H, Suttorp N, and Hippenstiel S. 2006. Listeria monocytogenes induced Rac1-dependent signal transduction in endothelial cells. Biochem Pharmacol 72[11], 1367-1374.
PubMed
25.Shi C, Forsbach-Birk V, Marre R, and McNealy TL. 2006. The Legionella pneumophila global regulatory protein LetA affects DotA and Mip. Int J Med Microbiol 296[1], 15-24.
PubMed.
26.Steinmüller M, Srivastava M, Kuziel WA, Christman JW, Seeger W, Welte T, Lohmeyer J, and Maus UA. 2006. Endotoxin induced peritonitis elicits monocyte immigration into the lung: implications on alveolar space inflammatory responsiveness. Respir Res 7, 30.
PubMed
27.Wellinghausen N, Straube E, Freidank H, von Baum H, Marre R, and Essig A. 2006. Low prevalence of Chlamydia pneumoniae in adults with community-acquired pneumonia. Int J Med Microbiol 296[7], 485-491.
PubMed
28.Welte T, Marre R, Suttorp N and Kompetenznetzwerk "Ambulant erworbene Pneumonie" (CAPNETZ). 2006. Was gibt es Neues in der Behandlung der ambulant erworbenen Pneumonie ? [What is new in the treatment of community-acquired pneumonia?]. Med Klin (Munich) 101[4], 313-320.
PubMed
29.Witzenrath M, Ahrens B, Kube SM, Braun A, Hoymann HG, Hocke AC, Rosseau S, Suttorp N, Hamelmann E, and Schütte H. 2006. Detection of allergen-induced airway hyperresponsiveness in isolated mouse lungs. Am J Physiol Lung Cell Mol Physiol 291[3], L466-L472.
PubMed
30.Witzenrath M, Gutbier B, Hocke AC, Schmeck B, Hippenstiel S, Berger K, Mitchell TJ, de los Toyos JR, Rosseau S, Suttorp N, and Schütte H. 2006. Role of pneumolysin for the development of acute lung injury in pneumococcal pneumonia. Crit Care Med 34[7], 1947-1954.
PubMed
31.Witzenrath M, Ahrens B, Kube SM, Hocke AC, Rosseau S, Hamelmann E, Suttorp N, and Schütte H. 2006. Allergic lung inflammation induces pulmonary vascular hyperresponsiveness. Eur Respir J 28[2], 370-377.
PubMed

2005

1.Bergmann S, Rohde M, Preissner KT, and Hammerschmidt S. 2005. The nine residue plasminogen-binding motif of the pneumococcal enolase is the major cofactor of plasmin-mediated degradation of extracellular matrix, dissolution of fibrin and transmigration. Thromb Haemost 94[2], 304-311.
PubMed
2.Hamann L, Alexander C, Stamme C, Zähringer U, and Schumann RR. 2005. Acute-phase concentrations of lipopolysaccharide (LPS)-binding protein inhibit innate immune cell activation by different LPS chemotypes via different mechanisms. Infect Immun 73[1], 193-200.
PubMed
3.Hammerschmidt S, Wolff S, Hocke A, Rosseau S, Müller E, and Rohde M. 2005. Illustration of pneumococcal polysaccharide capsule during adherence and invasion of epithelial cells. Infect Immun 73[8], 4653-4667.
PubMed
4.Hippenstiel S. 2005. Interaktion pulmonaler Epithelzellen mit Streptococcus pneumoniae [Pneumococci -- epithelial interaction]. Pneumologie 59[12], 895-896.
PubMed
5.Kohlhammer Y, Schwartz M, Raspe H, and Schäfer T. 2005. Risikofaktoren für die ambulant erworbene Pneumonie (Community Acquired Pneumonia). Eine systematische Übersichtsarbeit [Risk factors for community acquired pneumonia (CAP). A systematic review]. Dtsch Med Wochenschr 130[8], 381-386.
PubMed
6.Krüll M, Maass M, Suttorp N, and Rupp J. 2005. Chlamydophila pneumoniae - Mechanisms of target cell infection and activation. Thrombosis and Haemostasis 94[2], 319-326.
PubMed
7.Maus UA, Wellmann S, Hampl C, Kuziel WA, Srivastava M, Mack M, Everhart MB, Blackwell TS, Christman JW, Schlöndorff D, Bohle RM, Seeger W, and Lohmeyer J. 2005. CCR2-positive monocytes recruited to inflamed lungs downregulate local CCL2 chemokine levels. Am J Physiol Lung Cell Mol Physiol 288[2], L350-L358.
PubMed
8.McNealy TL, Forsbach-Birk V, Shi C, and Marre R. 2005. The Hfq homolog in Legionella pneumophila demonstrates regulation by LetA and RpoS and interacts with the global regulator CsrA. J Bacteriol 187[4], 1527-1532.
PubMed
9.N'Guessan PD, Schmeck B, Ayim A, Hocke AC, Brell B, Hammerschmidt S, Rosseau S, Suttorp N, and Hippenstiel S. 2005. Streptococcus pneumoniae R6x induced p38 MAPK and JNK-mediated caspase-dependent apoptosis in human endothelial cells. Thromb Haemost 94[2], 295-303.
PubMed
10.Opitz B, Förster S, Hocke AC, Maass M, Schmeck B, Hippenstiel S, Suttorp N, and Krüll M. 2005. Nod1-mediated endothelial cell activation by Chlamydophila pneumoniae. Circ Res 96[3], 319-326.
PubMed
11.Pletz MWR. 2005. Ambulant erworbene Pneumonie. Der Pneumologe 2[1], 17-27.

12.Reinert RR, Haupts S, van der Linden M, Heeg C, Cil MY, Al-Lahham A, and Fedson DS. 2005. Invasive pneumococcal disease in adults in North-Rhine Westphalia, Germany, 2001-2003. Clin Microbiol Infect 11[12], 985-991.
PubMed
13.Reinert RR, Ringelstein A, van der Linden M, Cil MY, Al-Lahham A, and Schmitz FJ. 2005. Molecular epidemiology of macrolide-resistant Streptococcus pneumoniae isolates in Europe. J Clin Microbiol 43[3], 1294-1300.
PubMed
14.Rosseau S. 2005. Pneumokokkenpneumonie im Mausmodell [Pneumococcal pneumonia in a mouse model]. Pneumologie 59[6], 419-420.
PubMed
15.Rosseau S, Wiechmann K, Moderer S, Selhorst J, Mayer K, Krüll M, Hocke A, Slevogt H, Seeger W, Suttorp N, Seybold J, and Lohmeyer J. 2005. Moraxella catarrhalis--infected alveolar epithelium induced monocyte recruitment and oxidative burst. Am J Respir Cell Mol Biol 32[2], 157-166.
PubMed
16.Schmeck B, Beermann W, van Laak V, Zahlten J, Opitz B, Witzenrath M, Hocke AC, Chakraborty T, Kracht M, Rosseau S, Suttorp N, and Hippenstiel S. 2005. Intracellular bacteria differentially regulated endothelial cytokine release by MAPK-dependent histone modification. J Immunol 175[5], 2843-2850.
PubMed
17.Schröder NW, Diterich I, Zinke A, Eckert J, Draing C, von Baehr V, Hassler D, Priem S, Hahn K, Michelsen KS, Hartung T, Burmester GR, Göbel UB, Hermann C, and Schumann RR. 2005. Heterozygous Arg753Gln polymorphism of human TLR-2 impairs immune activation by Borrelia burgdorferi and protects from late stage Lyme disease. J Immunol 175[4], 2534-2540.
PubMed
18.Schröder NW, Meister D, Wolff V, Christan C, Kaner D, Haban V, Purucker P, Hermann C, Moter A, Göbel UB, and Schumann RR. 2005. Chronic periodontal disease is associated with single-nucleotide polymorphisms of the human TLR-4 gene. Genes Immun 6[5], 448-451.
PubMed
19.Seybold J, Thomas D, Witzenrath M, Boral S, Hocke AC, Bürger A, Hatzelmann A, Tenor H, Schudt C, Krüll M, Schütte H, Hippenstiel S, and Suttorp N. 2005. Tumor necrosis factor-alpha-dependent expression of phosphodiesterase 2: role in endothelial hyperpermeability. Blood 105[9], 3569-3576.
PubMed
20.Srivastava M, Jung S, Wilhelm J, Fink L, Bühling F, Welte T, Bohle RM, Seeger W, Lohmeyer J, and Maus UA. 2005. The inflammatory versus constitutive trafficking of mononuclear phagocytes into the alveolar space of mice is associated with drastic changes in their gene expression profiles. J Immunol 175[3], 1884-1893.
PubMed
21.Welte T, Marre R, and Suttorp N. 2005. New therapeutic strategies for community acquired pneumonia. Internist 46[12], 1354-1359.
PubMed

2004

1.Bergmann S, Rohde M, and Hammerschmidt S. 2004. Glyceraldehyde-3-phosphate dehydrogenase of Streptococcus pneumoniae is a surface-displayed plasminogen-binding protein. Infect Immun 72[4], 2416-2419.
PubMed
2.Elm C, Braathen R, Bergmann S, Frank R, Vaerman JP, Kaetzel CS, Chhatwal GS, Johansen FE, and Hammerschmidt S. 2004. Ectodomains 3 and 4 of human polymeric Immunoglobulin receptor (hpIgR) mediate invasion of Streptococcus pneumoniae into the epithelium. J Biol Chem 279[8], 6296-6304.
PubMed
3.Forsbach-Birk V, McNealy T, Shi C, Lynch D, and Marre R. 2004. Reduced expression of the global regulator protein CsrA in Legionella pneumophila affects virulence-associated regulators and growth in Acanthamoeba castellanii. Int J Med Microbiol 294[1], 15-25.
PubMed
4.Hallatschek W, Fiedler G, Kirschning CJ, Creutzburg F, Lamping N, Nüssler A, and Schumann RR. 2004. Inhibition of hepatic transcriptional induction of lipopolysaccharide-binding protein by transforming-growth-factor beta 1. Eur J Immunol 34[5], 1441-1450.
PubMed
5.Hamann L, Hamprecht A, Gomma A, and Schumann RR. 2004. Rapid and inexpensive real-time PCR for genotyping functional polymorphisms within the Toll-like receptor -2, -4, and -9 genes. J Immunol Methods 285[2], 281-291.
PubMed
6.Hamann L, Kumpf O, Müller M, Visintin A, Eckert J, Schlag PM, and Schumann RR. 2004. A coding mutation within the first exon of the human MD-2 gene results in decreased lipopolysaccharide-induced signaling. Genes Immun 5[4], 283-288.
PubMed
7.Hermann C, Gueinzius K, Oehme A, Von Aulock S, Straube E, and Hartung T. 2004. Comparison of quantitative and semiquantitative enzyme-linked immunosorbent assays for immunoglobulin G against Chlamydophila pneumoniae to a microimmunofluorescence test for use with patients with respiratory tract infections. J Clin Microbiol 42[6], 2476-2479.
PubMed
8.Igel L, Helbig JH, and Lück PC. 2004. Isolation and characterization of a nonfluorescent strain of Legionella parisiensis. J Clin Microbiol 42[6], 2877-2878.
PubMed
9.Krüll M, Kramp J, Petrov T, Klucken AC, Hocke AC, Walter C, Schmeck B, Seybold J, Maass M, Ludwig S, Kuipers JG, Suttorp N, and Hippenstiel S. 2004. Differences in cell activation by Chlamydophila pneumoniae and Chlamydia trachomatis infection in human endothelial cells. Infect Immun 72[11], 6615-6621.
PubMed
10.Lück PC, Igel L, Helbig JH, Kuhlisch E, and Jatzwauk L. 2004. Comparison of commercially available media for the recovery of Legionella species. Int J Hyg Environ Health 207[6], 589-593.
PubMed
11.Marre R and von Baum H. 2004. Welche Erreger machen krank bei der ambulant erworbenen Pneumonie? [Which pathogens occur in community acquired pneumonia? First results of CAPNETZ]. Med Welt 55[10], 319-321.
Die Medizinische Welt
12.Maus UA, Srivastava M, Paton JC, Mack M, Everhart MB, Blackwell TS, Christman JW, Schlöndorff D, Seeger W, and Lohmeyer J. 2004. Pneumolysin-induced lung injury is independent of leukocyte trafficking into the alveolar space. J Immunol 173[2], 1307-1312.
PubMed
13.Opitz B, Püschel A, Schmeck B, Hocke AC, Rosseau S, Hammerschmidt S, Schumann RR, Suttorp N, and Hippenstiel S. 2004. Nucleotide-binding oligomerization domain proteins are innate immune receptors for internalized Streptococcus pneumoniae. J Biol Chem 279[35], 36426-36432.
PubMed
14.Reinert RR, Franken C, van der Linden M, Lütticken R, Cil M and Al-Lahham A. 2004. Molecular characterisation of macrolide resistance mechanisms of Streptococcus pneumoniae and Streptococcus pyogenes isolated in Germany, 2002-2003. Int J Antimicrob Agents 24[1], 43-47.
PubMed
15.Reinert RR. 2004. Bedeutung von Pneumokokken bei der ambulant erworbenen Pneumonie (CAP) [Importance of Streptococcus in community acquired pneumonia(CAP)]. Med Welt 55[10], 322-326.
Die Medizinische Welt
16.Rosseau S, Schmeck B, and Suttorp N. 2004. Pathogenese der Pneumonie [Pathogenesis of pneumonia – mechanisms of lung innate immunity]. Med Welt 55[10], 337-341.
Die Medizinische Welt
17.Rödel J, Prochnau D, Prager K, Baumert J, Schmidt KH, and Straube E. 2004. Chlamydia pneumoniae decreases smooth muscle cell proliferation through induction of prostaglandin E2 synthesis. Infect Immun  72[8], 4900-4904.
PubMed
18.Rupp J, Droemann D, Goldmann T, Zabel P, Solbach W, Vollmer E, Branscheid D, Dalhoff K, and Maass M. 2004. Alveolar epithelial cells type II are major target cells for C. pneumoniae in chronic but not in acute respiratory infection. FEMS Immunol Med Microbiol 41[3], 197-203.
PubMed
19.Schmeck B, Zahlten J, Moog K, van Laak, V, Huber S, Hocke AC, Opitz B, Hoffmann E, Kracht M, Zerrahn J, Hammerschmidt S, Rosseau S, Suttorp N, and Hippenstiel S. 2004. Streptococcus pneumoniae-induced p38 MAPK-dependent phosphorylation of RelA at the interleukin-8 promotor. J Biol Chem  279[51], 53241-53247.
PubMed
20.Schmeck B, Gross R, N'Guessan PD, Hocke AC, Hammerschmidt S, Mitchell TJ, Rosseau S, Suttorp N, and Hippenstiel S. 2004. Streptococcus pneumoniae-induced caspase 6-dependent apoptosis in lung epithelium. Infect Immun 72[9], 4940-4947.
PubMed
21.Schmitz-Esser S, Linka N, Collingro A, Beier CL, Neuhaus HE, Wagner M, and Horn M. 2004. ATP/ADP translocases: a common feature of obligate intracellular amoebal symbionts related to Chlamydiae and Rickettsiae. J Bacteriol 186[3], 683-691.
PubMed
22.Schröder NW, Heine H, Alexander C, Manukyan M, Eckert J, Hamann L, Göbel UB, and Schumann RR. 2004. Lipopolysaccharide binding protein binds to triacylated and diacylated lipopeptides and mediates innate immune responses. J Immunol 173[4], 2683-2691.
PubMed
23.Schweiger B. 2004. Viren als Ursache der ambulant erworbenen Pneumonie [Viruses causing community acquired pneumonia]. Med Welt 55[10], 327-331.
Die Medizinische Welt
24.Walter C, Zahlten J, Schmeck B, Schaudinn C, Hippenstiel S, Frisch E, Hocke AC, Pischon N, Kuramitsu HK, Bernimoulin JP, Suttorp N, and Krüll M. 2004. Porphyromonas gingivalis strain-dependent activation of human endothelial cells. Infect Immun 72[10], 5910-5918.
PubMed
25.Weber M. 2004. Struktur der Informationstechnologie in einem Kompetenznetzwerk [Structure of the information technology in a competence network]. Med Welt 55[10], 315-318.
Die Medizinische Welt
26.Welte T, Suttorp N, and Marre R. 2004. CAPNETZ - Community-acquired pneumonia competence network. Infection 32[4], 234-238.
PubMed
27.Welte T, Marre R, and Suttorp N. 2004. Das Kompetenznetzwerk Ambulant erworbene Pneumonie (CAPNETZ). Ein erster Zwischenbericht. [Competence network "community acquired pneumonia" (CAPNETZ). A first interim report].  Internist (Berl) 45[4], 393-401.
PubMed
28.Welte T. 2004. Therapie der ambulant erworbenen Pneumonie [Treatment of community acquired pneumonia]. Med Welt 55[10], 332-336.
Die Medizinische Welt

2003

1.Bergmann S, Wild D, Diekmann O, Frank R, Bracht D, Chhatwal GS, and Hammerschmidt S. 2003. Identification of a novel plasmin(ogen)-binding motif in surface displayed alpha-enolase of Streptococcus pneumoniae. Mol Microbiol 49[2], 411-423.
PubMed
2.Reinert RR, Muckel S, Al Lahham A, Spratt BG, Brueggemann AB, Hakenbeck R, and Lutticken R. 2003. Characterization of German penicillin non-susceptible serotype 23F pneumococci using multilocus sequence typing. J Med Microbiol 52[Pt 11], 981-987.
PubMed
3.Reischl U, Lehn N, Simnacher U, Marre R, and Essig A. 2003. Rapid and standardized detection of Chlamydia pneumoniae using LightCycler real-time fluorescence PCR. Eur J Clin Microbiol Infect Dis 22[1], 54-57.
PubMed
4.Schröder NW, Morath S, Alexander C, Hamann L, Hartung T, Zahringer U, Göbel UB, Weber JR, and Schumann RR. 2003. Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. J Biol Chem 278[18], 15587-15594.
PubMed
5.Schröder NW, Hermann C, Hamann L, Göbel UB, Hartung T, and Schumann RR. 2003. High frequency of polymorphism Arg753Gln of the Toll-like receptor-2 gene detected by a novel allele-specific PCR. J Mol Med 81[6], 368-372.
PubMed
6.Tuschy P, Welte T, Marre R, Suttorp N, Lorenz J, Fätkenheuer G, and Ewig S. 2003. Das schwere akute Atemwegssyndrom [SARS--Severe Acute Respiratory syndrome]. Pneumologie 57[5], 256-258.
PubMed
7.Weber JR, Freyer D, Alexander C, Schröder NW, Reiss A, Küster C, Pfeil D, Tuomanen EI, and Schumann RR. 2003. Recognition of pneumococcal peptidoglycan: an expanded, pivotal role for LPS binding protein. Immunity 19[2], 269-279.
PubMed
8.Welte T, Marre R, and Suttorp N. 2003. CAPNetz - Kompetenznetzwerk ambulant erworbene Pneumonie: Strukturen und Ziele [CAPNet--network of competence for community acquired pneumonia: structures and aims]. Pneumologie 57[1], 34-41.
PubMed

2002

1.Poppert S, Essig A, Marre R, Wagner M, and Horn M. 2002. Detection and differentiation of chlamydiae by fluorescence in situ hybridization. Appl Environ Microbiol 68[8], 4081-4089.
PubMed

2001

1.Horn M and Wagner M. 2001. Evidence for additional genus-level diversity of Chlamydiales in the environment. FEMS Microbiol Lett 204[1], 71-74.
PubMed